CJC-1295 No-DAC
Synthetic GHRH analog (1–29 fragment) without the Drug-Affinity-Complex albumin linker. Referenced in pulsatile GH-release research alongside ipamorelin.
What the literature says.
Mechanism of action
Binds the GHRH receptor on somatotrophs, increasing cAMP and GH transcription/release. The four amino-acid substitutions resist DPP-IV cleavage and preserve receptor affinity.
Preclinical summary
CJC-1295 (no-DAC), also called Mod GRF 1-29, is a tetrasubstituted 30-amino-acid GHRH analog used in pulsatile GH-release studies without extended half-life behavior.
Safety
Research material only. Not a drug, supplement, or food product. No human or animal administration is supported or implied. Handling should follow the purchaser's institutional biosafety and chemical hygiene protocols.
Shipping & storage
Ships overnight in insulated packaging with ice packs when lab conditions require. Store lyophilized powder at 2–8°C. After reconstitution, store at 2–8°C and use within standard stability windows documented on the lot-specific Certificate of Analysis.
The compound, in numbers.
Research use only.
These products are intended for laboratory research purposes only and are not for human or animal consumption.
The statements on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
